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ABSTRACT:

Background: Isocyanates are one of the most commonly reported causes of occupational
asthma; however, the risks of developing isocyanate asthma in modern production
facilities remain poorly defined. The purpose of the present investigation was to evaluate
TDI exposure and respiratory health among an inception cohort of workers during their
first year of employment at a new polyurethane foam production factory.

Methods: Forty-nine newly hired workers were evaluated pre-employment, 6-months,
and 12-months post-employment through questionnaire, spirometry and TDI-specific
serology. Airborne TDI levels were monitored by fixed-point air sampling and limited
personal sampling. Qualitative surface SWYPE™ tests were performed to evaluate
potential sources of skin exposure.

Results: Airborne TDI levels were low; over 90% of fixed-point air measurements were
below the limit of detection (0.1 ppb). Over the first year of employment, 12 of the 49
original workers (24.5%) were lost to follow-up, no additional workers were enrolled,
and seven of the 49 original workers (14.2%) developed either new asthma symptoms
(N=3), TDI-specific IgG (N=1), new airflow obstruction (N=1) and/or a decline in FEV1
≥ 15% (N=3), findings that could indicate TDI-related health effects. The prevalence of
current asthma symptoms was significantly higher in the workers lost to follow-up
compared to those who completed the study (25% vs 2.7%; p=0.04).

Conclusions: The findings suggest possible early TDI-related health effects in a modern
polyurethane production plant. These findings also highlight the need for further
longitudinal evaluation of these workers and the challenges of studying workers at risk
for isocyanate asthma.
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6
INTRODUCTION:

Isocyanates are highly reactive chemical compounds characterized by the presence of
N=C=O groups widely used for the production of a variety of products including foams,
adhesives, coating materials, and elastomers1,2. There are many different forms of
isocyanates used in the various industries, of which the most commonly used are the
monoisocyanate (one functional N=C=O group per molecule) methyl isocyanate (MIC)
and the diisocyanates (two functional N=C=O groups per molecule) toluene diisocyanate
(TDI), diphenyl-methane diisocyanate (MDI), hexamethane diisocyanate (HDI), and
isophorone diisocyanate (IPDI)2,3. Previous studies have clearly shown that exposure to
isocyanates may lead to occupational asthma1.

Although isocyanates remain one of the most commonly reported causes of occupational
asthma4, the prevalence, incidence, and risk factors for development of isocyanate asthma
under current work conditions are not well defined, as there have been few recent
epidemiology studies of isocyanate-exposed workers, despite the increasing use of
polyurethane products in numerous industries5. More recent studies have largely been
limited to cross-sectional studies of end-users such as spray painters, rather than factory
workers producing polyurethane products6,7. Further, the majority of epidemiology
studies of isocyanate-exposed workers, past or recent, have been cross-sectional in design,
and prone to the healthy worker effect8. The few longitudinal studies have been
conducted largely at primary isocyanate production facilities9,10, rather than secondary
polyurethane production plants.
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The present investigation of workers from a newly built modern TDI-based polyurethane
foam factory in Eastern Europe provides a rare opportunity to evaluate the risk of TDI
asthma among workers employing state-of-the-art polyurethane foam production
technology. The factory is located in the city of Baia Mare in the Maramureş region of
northwest Romania, approximately 600 kilometres away from the capital city of
Bucharest, 70 kilometres away from the Hungarian border, and 50 kilometres away from
the Ukrainian border. A prospective inception cohort study was initiated with the initial
group of workers (N=49) employed at the plant.

Respiratory health and TDI-specific IgG and IgE were assessed pre-employment, and
reassessed along with exposure potential at 6-month intervals post-employment. Data
from the initial 12-month study period showed that almost 25% of the initial workers
were lost to follow-up and 14.2% had findings that could indicate risk for the
development of isocyanate asthma.

The data contained in the present investigation were obtained from January 2010 to
January 2011 as an international collaborative research effort between investigators at the
Yale University School of Medicine in the New Haven, Connecticut, United States and
the Environmental Health Center in Cluj-Napoca, Romania. After careful compilation of
the data, analysis and interpretation were subsequently undertaken and the final findings
are presented in this report. The author of this Yale University School of Medicine thesis,
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W.G., takes full responsibility for the contents and all efforts have been made to ensure
the accuracy of the data.
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SPECIFIC AIMS:

1) To characterize TDI exposure, TDI sensitization, and TDI-health effects in a modern TDI
polyurethane plant via air sampling monitoring, questionnaires, serum antibody
immunoassays, and spirometry.
2) To better understand the incidence and natural history of TDI sensitization and TDIinduced occupational asthma (OA) through the longitudinal inception cohort study design.
3) To apply the results from the study to reduce TDI exposures and the risk of TDIsensitization and related health effects.
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HYPOTHESIS:

Despite the presence of state of the art control measures to limit the exposure to
isocyanates at the newly built, modern polyurethane production factory, opportunities for
isocyanate exposure, sensitization and subsequent health effects in the workers may occur.
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METHODS:

Overall Study Design:

The study was conducted at a newly built modern TDI polyurethane foam factory in
Eastern Europe with an on-site health clinic. The entire initial production workforce
(N=49) was recruited to participate in the study following a brief informational session,
during which employees learned about the study and informed consent was obtained.
Workers completed an interviewer-administered questionnaire, underwent spirometry
testing, and provided peripheral blood for serology pre-employment and at 6 and 12
months after employment. The human subjects study protocol was approved by oversight
committees of the Human Investigations Committee (HIC) at Yale University, New
Haven, Connecticut, United States, and the Institutional Review Board at Environmental
Health Center, Cluj-Napoca, Romania.

The HIC protocol was predominantly prepared and updated by Dr. Meredith Stowe at the
Yale Occupational and Environmental Medicine Program. I provided input and
recommendations where appropriate.

Questionnaire:

Pre-employment questionnaire:
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A pre-employment questionnaire was created to gather baseline data regarding: a)
demographics; b) respiratory health; c) smoking history; d) general health; e)
employment history; f) personal protective equipment; g) ventilation at the workplace; h)
cleaning at the workplace.

This baseline questionnaire was developed by our colleagues at the Environmental Health
Center in Romania based on previous experience with regional workplace populations
and was implemented prior to employment for the workers.

6-month follow-up questionnaire:

Questionnaires were administered in an interview-based format. Workers were invited to
the health clinic, as a private environment, for completion of the questionnaires. The
workers were informed that their employers did not have any access to their confidential
responses and were asked to answer each question truthfully. If they did not have an
answer to a question, they answered with the phrase “I Don’t Know”. Follow-up
interviewer-administered questionnaires contained additional questions regarding skin
exposure, use of personal protective equipment (PPE) and temporal relationships of
respiratory symptoms to work. Asthma-like symptoms included at least one of the
following: 1) cough, 2) wheeze, 3) chest tightness, and 4) shortness of breath, and were
classified as work-related if they worsened while at work and improved while away from
work. Possible TDI skin exposure was determined from the questionnaire by assessing
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whether workers reported frequently touching or handling recently cured polyurethane
foams.

I was responsible for creating the follow-up questionnaire and providing directions for
implementation. The questionnaire was administered by our colleagues in Romanian with
consultation from our team at the Yale Occupational and Environmental Medicine
Program. Once the gathering of data was complete, I compiled the data and performed
the analyses.

Spirometry Testing:

Spirometry at 6 and 12 months was performed with the PC Portable Microlyser (P&A
Medical Limited, Blackrod, UK) according to ATS/ERS Guidelines11, including proper
calibration and a minimum of 3 acceptable spirograms. Due to logistical issues preemployment spirometry was performed on only 24 of the workers and at an alternate
facility.

The largest FVC and FEV1 from all acceptable curves were chosen and compared to
predicted values and lower limit of normal (LLN), and airflow obstruction was defined as
FEV1/FVC < LLN, as recommended by the ATS/ERS12. Excessive longitudinal decline
in FEV1 over the follow-up period was identified using a threshold of 15% decline from
baseline, as recommended by ATS and ACOEM12,13.
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All of the spirometry testing was performed by our colleagues in Romania. Once the
testing was complete, I compiled all of the spirometry data and performed the analyses of
the data.

Serology Testing:

Venipuncture:
Workers were invited to the health clinic at the factory site for venipuncture conducted by
a trained and licensed laboratory nurse. The clinic was located in a building
approximately 500 m away from the raw materials and manufacturing complex and was
separated into three rooms: a) office and administrative duties room; b) exam and
medicines room; c) venipuncture room.

The venipuncture room had the approximate dimensions of 3 m x 4 m and contained a
sink, a counter, and a few chairs. Each worker was asked to sit down on the chair and
extend each arm for the nurse to examine. Once the arm with the vein deemed most
suitable for venipuncture was chosen, the worker extended the chosen arm and rested the
arm on top of the back of a chair. The nurse then applied an elastic band on the arm
proximal to the site of venipuncture and asked the worker to make a fist with that arm. A
BD Vacutainer SST Plus Blood Collection Tube (Becton, Dickenson and Company,
Franklin Lakes, NJ) was attached to a standard phlebotomy needle and the worker’s
superficial cubital fossa was wiped with a cotton swab covered with isopropyl alcohol.
The needle was then inserted into a suitable vein in the superficial cubital fossa and the
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Vacutainer Tube began to fill with blood. Before the tube fully filled with blood, the
rubber band was released from the worker’s arm and the worker was asked to release the
fist. When the tube was filled to approximately 10 mL of blood, the nurse released the
tube from the needle. The needle was subsequently released and the cotton swab was
applied to the place at which the needle was inserted. The blood was subsequently
centrifuged at 400 x g and the serum fraction was aliquoted, and cryopreserved at -80°C.

TDI-Specific Antibodies:
TDI-specific IgG and IgE levels in serum samples from each worker at baseline, 6-, and
12-months post-employment were measured using enzyme linked immunosorbent assays
(ELISA)14. TDI-albumin conjugates (10 μg/ml) prepared by mixed phase (vapor/liquid)
exposure methods were used to coat 96-well NUNC Maxisorp ELISA plates (Thermo
Fisher Scientific Inc., Waltham, MA), followed by blocking with 3% dry milk in
phosphate buffered saline (PBS). Workers’ sera were diluted in 3% milk + PBS + 0.05%
Tween 20 and TDI-specific IgG was detected with horseradish peroxidase linked antihuman IgG antibodies from Pharmingen (San Jose, CA), and expressed as an end-titer.
For detecting TDI-specific IgE, plates were developed with biotinylated goat anti-human
IgE (Bethyl; Montgomery, TX) followed by alkaline phosphatase conjugated streptavidin,
and pNPP substrate from Thermo Fisher Scientific Inc. Plates were read using BioRad
Model 550 Microplate Reader at dual wavelengths of 450 nm/550 nm for TDI-specific
IgG assays and at 415 nm/550 nm for TDI-specific IgE assays.
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The blood draws were completed by our colleagues in Romania and the antibody assays
were performed by Jian Liu with direction from Dr. Wisnewski at the Yale Department
of Internal Medicine. I was present in the laboratory for a significant portion of the assays.
Once the results were available, I performed additional analyses.

Exposure Assessment:

Airborne exposure information from the factory’s foaming hall and cutting area was
collected through continuous fixed-point air sampling with 18 minute sampling intervals
using ChemLogic 1 direct reading instruments (DOD Technologies, Inc., Chrystal Lake,
IL). Personal quantitative sampling was performed using flow pumps from Gilian
(Sensidyne, LP, Clearwater, FL) and DuPont (E.I. du Pont de Nemours and Co.,
Wilmington, DE), which were calibrated before and after sampling to approximately 300
cc/min. Personal breathing zone samples were collected at 0.3 L/minute flow for 20-30
minutes on silica gel coated cartridges, and preserved at 4°C until analysis. TDI was
extracted from cartridges by adding 2 mL methanol with shaking for two minutes.
Following filtration, samples were analyzed by GC-MS (Shimadzu QP 2010 Plus; Kyoto,
Japan), on an AT-502.2 capillary column, 60 m length, 0.32 mm diameter and 1.8 μm
film thickness. Surface exposure was qualitatively assessed using colorimetric SWYPE™
wipes that develop color on contact with TDI, with depth of color roughly proportional to
TDI concentration (Colormetric Laboratories, Inc., Des Plaines, IL)15. Skin exposure was
similarly evaluated using the colorimetric SWYPE™ on a single foam line worker.
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Workers’ Exposure Risk Groups:

Workers were grouped with regard to their potential risk of TDI exposure (high, medium,
low), based on their primary work location and duties, with the input of an industrial
hygienist who had evaluated the plant. Workers who spent most of their time in the
foaming hall, where foam was produced from raw materials including TDI were
classified into the high exposure risk group; those who spent most of their time in the
cutting area where foam blocks are cut to size after a period of curing, in the laboratory,
where production samples are tested, and in maintenance were included in the medium
exposure risk group, and the remaining workers, such as administrative, quality and
warehouse, were included in the low exposure risk group.

The exposure analyses were jointly performed by Judy Sparer and myself during our site
visit to Romania and upon return to the Yale Occupational and Environmental Medicine
Program. I was responsible for compiling the exposure data and for performing additional
analyses.

Statistical Analysis:

Statistical analysis was performed using SAS (SAS Institute, Cary, NC). Summary
descriptive statistics were calculated for baseline variable characteristics. Associations
between categorical variables were tested using Fisher’s exact test, while continuous
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variables were compared using generalized linear modeling. A p value < 0.05 was
considered statistically significant.

Statistical analyses were predominantly performed by Dr. Slade at the Yale Occupational
and Environmental Medicine Program. However, I was present to answer questions and
for consultation for the majority of the analyses performed.
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RESULTS:

Plant, Demographics and Workforce Exposure Risk Groups:

The plant, a new large modern facility with extensive engineering controls, was built to
produce TDI-based polyurethane foams for home furnishings and related uses.
Demographic and workforce characteristics of the initial 49 workers who were hired and
enrolled, the 37 workers remaining at one-year follow-up in the study, and the 12 workers
lost to follow-up are summarized in Table I. No new employees were enrolled during this
time period. At baseline, the workers were predominately male (69.4%), middle-aged
(mean 39 years), smokers (40.8% current smokers), and none reported a past diagnosis of
asthma. The potential risk of TDI exposure was estimated to be high for 13 subjects
(26.5%) who worked in the foaming hall, medium for 28 subjects (57.1%) who worked in
cutting, maintenance and laboratory areas, and low for the remaining 8 subjects (16.3%),
based on job category. There were no significant differences in demographics or
exposure risk group, comparing baseline, follow-up and lost to follow-up groups of
workers.

Exposure Assessment:

Continuous fixed-point air sampling performed in the foaming hall and cutting areas over
the 1-year study period showed that airborne TDI concentrations were low, below the
limit of detection (LOD) of 0.1 ppb in over 87% of the air recordings obtained in the
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cutting areas and over 95% of the readings from the foaming hall. Over the entire 12month study period, the maximum TDI vapor concentration recorded was 10.0 ppb in the
foaming hall and 5.4 ppb in the cutting area, and no air sampling period exceeded the
threshold limit value (TLV) for a 8-hr workday assigned by the American Conference of
Governmental Industrial Hygienists (ACGIH) for TDI (0.005 ppm; 36 ug NCO/m3), the
occupational exposure limit used in the United Kingdom, and many European countries16.
The brief peak exposures recorded were also well below the Permissible Exposure Limit
(PEL) ceiling for TDI (0.020 ppm) set by the Occupational Safety and Health
Administration (OSHA)16.

Representative TDI air sample data from the cutting area for a 6-week period between
November and December 2010 is shown in Figure 1. While most levels are below the
LOD (0.1 ppb), brief intermittent TDI exposures were noted, the majority of these below
5 ppb. A 6-day period within the 6-week period shows several peak exposures in the
cutting area on production days between 10 am and 2 pm (peak production time periods)
and non-detectable airborne TDI levels during non-production hours (e.g. weekends).
Consistent with the fixed-point air sample monitoring, the limited personal quantitative
air sampling performed on 7 different workers in the foaming hall and cutting area all
showed TDI levels below the LOD.

The potential for TDI skin exposure was evaluated using TDI qualitative SWYPE™
sampling of selected environmental surfaces in the plant and worker questionnaires.
Eleven surfaces in the cutting room and foaming hall, including tables, handrails,
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machinery, and foam were sampled. Three of the 11 (27.2%) surface SWYPE™ samples
were positive, including two SWYPE™ samples taken of the paper lining that had been
peeled from the cured polyurethane foam at the end of the line, before cutting the foam.
Additionally the hands of one worker who had just cleaned the foaming head sampled
positive for TDI using the SWYPE™ wipes. Based on the questionnaire data, thirteen
workers (28.2%) reported potential TDI skin contact (e.g. from handling freshly cured
product or recently used machine part).

Workers Lost to Follow-up:

Twelve of the initial 49 workers (24.5%) in this inception cohort were no longer available
for follow-up by the end of their first 12-months of employment, as shown in Tables I
and II. Six of the 49 workers (20.4%) were no longer working at the plant at the time of
follow-up, one of whom was reported as being "sick" at 6-month follow-up, 4 workers
were “unavailable” during follow-up, and two workers refused subsequent participation.
There were no differences in demographics or exposure risk group, comparing the lost to
follow-up group to the other workers.

Asthma Symptoms:

The symptom data at baseline, 6 and 12-month follow-up is summarized in Table II,
including the available data on the 12 workers lost to follow-up during this 1 year followup period. The overall prevalence of symptoms was low, and similar comparing baseline

22
and the 2 follow-up times. However, a significantly higher proportion of workers lost to
follow-up (3/12; 25%) reported current asthma-like symptoms, compared to those who
remained working and enrolled in the study (1/37; 2.7%) (p=0.04). However, considering
only those workers who were lost to follow-up and had left the company compared to
those who were reportedly still employed, 16.7% (1/6) who left the company had
reported current asthma symptoms compared to 7.0% (3/43) who were still employed.
The only worker who reported new asthma symptoms that were work-related had
resigned and left the workplace. Three workers reported new asthma-like symptoms over
the 12 months (7.1%), including the worker noted above, who reported a relationship
between his symptoms and work (at 6 months) and at 12 months was lost to follow-up (as
noted above).

Isocyanate Serology:

Serum TDI-specific IgG and IgE results are shown in Table II, with no significant
differences noted between the groups of workers. Of note, one worker, a maintenance
worker with prior occupational TDI exposure, exhibited an elevated TDI-specific IgG
(titer 1:160) pre-employment, which was then negative at 6 and 12 months after
employment at this new plant. Another worker developed a positive TDI-IgG (titer 1:40)
between employment and the 6-month follow-up, which then resolved by 12 months,
during which time the worker had been transferred to a low exposure job. All TDIspecific IgE tests were negative at 6 months, and not tested at the other time points due to
sample limitations.
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Spirometry:

The results of spirometry testing at baseline, 6 months and 12 months follow-up are
shown in Table I. Spirometry was obtained on all workers not lost to follow-up at 6 and
12 months. However, due to logistical issues, spirometry was available on only 24 of the
49 (49 %) workers at baseline, and the baseline testing was performed at a different site
than the follow-up testing. There were no significant differences in FEV1, FVC and
FEV1/FVC comparing baseline, follow-up and the workers lost to follow-up, or when
comparing only those workers with spirometry data at all 3 time points (N=16). Of note,
no workers had airflow obstruction (FEV1/FVC < LLN) at baseline, 1 worker (2.4%) had
airflow obstruction at 6 months (initial test for that worker) and 2 workers (5.4%) had
airflow obstruction at 12 months, one of whom had new onset airflow obstruction (1/37;
2.7%). Additionally, a decrease in FEV1 of > 15% was noted in 3 workers (9.1%)
between baseline and 12 months, one of whom reported new asthma symptoms.

Relationships with Exposure Risk:

The relationships between exposure risk groups, health outcomes, reported skin exposure
and loss to follow-up were explored (Table III). No significant associations were
observed between the assigned exposure risk group, based on job category, and new
asthma-like symptoms, new eye irritation, baseline lung function, change in lung function
over the year of follow-up, or workers lost to follow-up. Self-reported glove use differed
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significantly between workers in the different exposure risk groups. All 13/13 workers
(100%) of the high exposure risk group reported glove use, while only 8/25 workers
(32.0%) in the medium risk group used gloves. The potential for skin exposure, reported
by 28.3% of the workers, was similar in all exposure groups.

Workers with Possible Early TDI-Related Health Effects:

Although the company reported no known cases of isocyanate-related allergy or asthma,
over the first year of follow-up 7 of the 49 original workers (14.2%) developed either
new asthma symptoms (N=3), a positive TDI-IgG (N=1), new airflow obstruction (N=1)
or a decline in FEV1 > 15% (N=3), findings that could indicate TDI-related health effects.
For example, one worker, a laboratory chemist, developed a 1:40 titer of TDI-IgG and
new-onset eye irritation during the first 6 months of employment, after which she
changed to a low exposure risk job, and at the 12 month follow-up evaluation both had
resolved. A second worker, from the cutting area, reported new asthma-like symptoms
that were work related at 6 months and was then lost to follow-up at the 1-year follow-up.
A third worker, from the warehouse (low exposure risk), developed new asthma-like
symptoms by 6 months, and exhibited a greater than >20% decrease in FEV1 between 6
and 12 months post-employment. Together the findings in these workers suggest possible
increased risk for isocyanate sensitization and asthma, despite very low measured
airborne TDI exposures. More thorough medical evaluation of selected workers, such as
bronchodilator testing or peak flow monitoring, was not possible.
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DISCUSSION:

To our knowledge this is the first longitudinal inception cohort study of polyurethane
foam production workers in a modern facility designed to minimize airborne TDI
exposures, despite the expanding use of polyurethane in numerous industries and types of
manufacturing. Data were obtained during the initial year of the modern new factory’s
operation, with longitudinal evaluation of workers pre-employment, and at 6-month
intervals post-employment. Measured airborne TDI levels were very low, well below
PELs for TDI established by advisory and/or regulatory agencies.

Over the first year of follow-up, 12 of the initial 49 workers (24.5%) were lost to followup and 7 workers (14.2%) developed findings that could indicate TDI-related health
effects. These findings highlight the potential risks of isocyanate exposure, even at very
low levels, and the need for further epidemiology studies, ideally longitudinal inception
cohort studies.

Several findings from this 1-year longitudinal follow-up of an inception cohort of
polyurethane foam production workers are notable. First, almost 25% of the initial
inception cohort of workers was lost to follow-up over the first year. A priori, we
expected excellent follow-up of the initial workers, given local economic considerations,
the modern facilities, government-mandated medical surveillance of workers, and the
established relationship between members of the investigative team and the plant. The
large proportion of workers lost to follow up, while unexpected, is consistent with other
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longitudinal studies of isocyanate exposed cohorts, where up to 50% (or more) of the
workers were lost to follow-up17-20, or where follow-up was not clearly detailed21,22.

A second notable finding from this study was the potential for exposure to TDI, despite
the modern facilities and intensive industrial hygiene efforts, including ventilation,
automated, enclosed production machinery, and continuous real-time monitoring of
airborne concentrations. Although most area air sample measurements were below the
limit of detection, and never exceeded OSHA’s ceiling PEL, or the more conservative
TLV recommended by the ACGIH and similar European advisory councils (see above),
TDI vapor levels from 0.5 to 5 ppb were commonly measured during peak foam
production hours (10 AM - 2 PM). Furthermore, intermittent low level spikes in TDI air
levels occurred in both the foaming hall, where workers expect potential exposure and
wear protective equipment, and the cutting area, where exposure is not expected and
workers rarely wear protective equipment.

The overall prevalence of asthma symptoms and/or immunologic sensitization to TDI
was low among workers that completed their first year of employment at this modern
TDI polyurethane production facility. However, 14.2% of the original workers developed
findings suggestive of possible TDI-related health effects (new asthma symptoms, TDIspecific IgG, new airflow obstruction, and/or a decline in FEV1 > 15%). These findings
should be considered in the context of (the lack of) available diagnostic tests for
isocyanate sensitization and asthma, as well as uncertainty regarding the natural history
of disease. While isocyanate asthma has been reported to occur within weeks to months
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of exposure, the latency period between onset of exposure, immune sensitization, and
asthma symptoms may vary and has been difficult to define4,10,18,23. With continuing
improvements in industrial hygiene and reduction of airborne TDI levels, the latency
period, if it occurs, may be further increased. More long-term follow-up of the current
cohort, while challenging, is needed, as well as further evaluation of those with findings
suggestive of possible isocyanate asthma, to better understand the risks of isocyanate
exposures, and to assess whether current work controls are effective at preventing
isocyanate sensitization and asthma.

This study data also demonstrated potential TDI skin exposure of the workers, based on
limited SWYPE™ qualitative testing and questionnaire data, which may represent
another exposure route (besides respiratory) capable of inducing systemic immune
sensitization. Notably, TDI was detected on surfaces that workers may touch when not
wearing gloves (such as handrails, table) and 28.2% of all workers reported potential TDI
skin contact by questionnaire. Site visits during the study documented extensive use of
respiratory and skin PPE in the foaming room during production, but more limited use of
PPE in the cutting room (occasional gloves), consistent with the questionnaire data. Also
noted was unprotected hand contact with uncured or just cured polyurethane during
cleaning of the “foaming head”, where the positive skin and surface SWYPE™ samples
were detected, and contact with just cured foam emerging from the production oven.

Based on the findings of the study, several recommendations have been made to further
protect the workers from exposure to isocyanates. Although careful, conscious design of
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the facilities has been implemented to limit airborne exposures, measures to protect
workers against skin exposure are suggested. Further testing should be performed with
greater sensitivity to ensure that the polyurethane foam is safe to handle when it is cut.
Additionally, gloves that are impervious to both isocyanates and other potential coexposures should be provided and enforced for workers cleaning the foaming head due to
potentially significant exposure to isocyanates.

Several limitations of the study should be recognized, mainly related to limited size of the
cohort, the limited follow-up time period, and the suboptimal spirometry. The size of the
inception cohort was constrained by the company's production plans and an automated
manufacturing process. As noted above, the 1-year follow-up duration limits insight into
the prevalence of TDI sensitization and asthma, which can take longer than 1 year to
develop, and almost 25% of the initial inception cohort was lost to follow-up. The
reason(s) workers resigned, refused, or were not present was not generally available.
Efforts are on-going to follow-up these workers. Further medical evaluation of the 7
workers with findings suggestive of possible isocyanate asthma could help clarify risk,
but was not feasible. Unfortunately baseline spirometry was obtained on less than half of
the workers and at a different facility, and the full spirometry data was not available,
limiting quality assessment and analysis. These considerations were taken into account in
interpreting the findings.

Another limitation of the study was the limited TDI air and skin exposure assessment and
the job-based assignment to exposure risk groups, which may have misclassified some
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workers. Airborne TDI levels were based almost exclusively upon fixed area samples,
which may not accurately reflect individual exposures, especially during selected tasks
such as cleaning and maintenance, and localized TDI air levels may have been higher
near the source. Methods for quantifying isocyanate skin exposure remain experimental;
thus, the present investigation relied upon questionnaire data and qualitative approaches
of assessment. The relatively small sample size and low prevalence of symptoms, TDIIgG and other outcomes limited statistical power to compare workers in the different
exposure risk groups. Limited funding also prohibited more extensive quantitative
exposure assessment.

In summary, the present investigation describes a unique inception cohort from a new
modern polyurethane foam factory with very low measured airborne TDI levels. Twelve
of the initial 49 workers (24.5%) were lost to follow-up in the first year. These workers
were significantly more likely to report current asthma symptoms, and also included the
only worker with new asthma symptoms that were work-related, suggesting a possible
healthy worker effect. Among the 37 workers that completed the study, 7 workers either
developed respiratory symptoms, TDI-specific IgG and/or changes in spirometry that
may represent early TDI-related health effects. Further longitudinal follow-up of the
current workforce, including those lost to follow-up, as well as better exposure
assessment, are needed to better characterize the risks of TDI exposure in modern
polyurethane production facilities.
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Table I. Demographic Characteristics and Workforce Exposure Risk Groups
Baseline
12 month
Workers lost to follow-up
Characteristic
N (% total)
N (% total)
N (% total)*
Total workers
49 (100)
37 (100)
12 (100)
Gender
Male
34 (69.4)
26 (70.3)
8 (66.6)
Female
15 (30.6)
11 (29.7)
4 (33.3)
Age (years)
Mean ± SD
39.1 ± 11.6
40.6 ± 11.8
37.8 ± 11.5
Range
20-59
21-59
24-59
Smoker
Current
20 (40.8)
15 (40.5)
5 (41.7)
Former
8 (16.3)
6 (16.2)
2 (16.7)
Never
21 (42.9)
16 (43.2)
5 (41.7)
Diagnosed asthma
Yes
0 (0.0)
0 (0.0)
0 (0.0)
Job risk group
Lowa
8 (16.3)
8 (21.6)
2 (16.7)
b
Medium
28 (57.1)
18 (48.6)
8 (66.7)
c
High
13 (26.5)
11 (29.7)
2 (16.7)
N=number of workers/total number of workers for which data were available (%)
*
Six workers were no longer working at the plant, 4 were not present, and 2 refused to participate.
a
Administrative/quality and engineer/fire guard workers
b
Cutting/laboratory/maintenance workers
c
Foaming hall workers
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Table II. Questionnaire, Spirometry, and Serology Data at Baseline and Follow-up
Baseline*
6 month*
12 month*
Lost to Follow-up**
N=49
N=42
N=37
N=12
Overall symptoms n (%)
3/49 (6.1)

3/42a (7.1)

1/37 (2.7)

3/12 (25.0)e

New asthma symptoms

N/A

3/42 (7.1)

0/37 (0.0)

1/9 (11.1)

New eye irritation

N/A

1/42 (2.4)

1/37 (2.7)

0/9 (0.0)

FEV1 L (mean + SD); %
pred (mean + SD)

3.27 + 0.75
88.0 + 12.0

3.77 + 0.76
98.0 + 13.0

3.88 + 0.99
99.0 + 15.0

3.72 + 0.85
99.0 + 14.0

FVC L (mean + SD); %
pred (mean + SD)

4.02 + 0.90
86.0 + 11.0

4.48 + 0.85
94.0 + 13.0

4.55 + 1.08
94.0 + 14.0

4.46 + 1.04
95.0 + 15.0

FEV1 / FVC (mean + SD)

0.82 + 0.08

0.84 + 0.07

0.85 + 0.09

0.84 + 0.04

FEV1/FVC < LLN (n, %)

0/23 (0.0)

1/42 (2.4)

2/37 (5.4)

0/9 (0.0)

N/A

0/19 (0.0)

3/33 (9.1)

0/3 (0.0)

1/48b (2.1)

1/39c (2.6)

0/37 (0.0)

0/11 (0.0)

0/39 (0.0)

NT

0/12 (0.0)

Current asthma symptoms

Spirometry

Decline in FEV1 > 15%
(n, %)
ELISA
TDI IgG positive
TDI IgE positive
*

d

NT

Number of workers/total number of workers for which data were available (%)
Of the 12 subjects lost to follow-up, 10 were no longer at work at the plant, 4 were not present and 2 refused to
participate.
a
One worker reported work-related asthma symptoms at 6 month follow-up.
b
One worker with TDI-IgG at baseline tested negative in the follow-up period.
c
Another worker with negative IgG at baseline developed positive IgG at 6-month follow-up.
d
NT=Not tested
e
A higher percentage of subjects lost to follow-up (25%) reported current asthma conditions than those that were not lost to
follow-up (2.7%) (p=0.04). Fisher’s exact test was utilized to test for association (categorical outcomes). Analysis of
variance was used to test for differences in means for continuous outcomes.
**
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Table III. Comparison Across Workforce Exposure Risk Groups Over 1 Year Follow-Up
Period
All*
Low risk*
Medium risk*
High risk*
N=49
N=8
N=28
N=13
New asthma
3/46 (6.5)
1/8 (12.5)
2/25 (8.0)
0/13 (0.0)
symptoms
New eye irritation
2/42 (4.8)
0/8 (0.0)
2/22 (9.1)
0/12 (0.0)
New airflow
1/40 (2.5)
1/6 (16.7)
0/22 (0.0)
1/12 (0.0)
obstruction:
(FEV1/FVC < LLN)
Decline in
3/40 (7.5)
1/6 (16.7)
2/22 (9.1)
0/12 (0.0)
FEV1 >15%
Gloves worn**
25/46 (54.3)
4/8 (50.0)
8/25 (32.0)
13/13 (100.0)
Self-reported skin
13/46 (28.3)
2/8 (25.0)
8/25 (32.0)
3/13 (23.1)
exposure
Workers lost to
12/49 (24.5)
2/8 (25.0)
8/28 (28.6)
2/13 (15.4)
follow-up
*Number of workers / total number in each category (% total)
** p < 0.05 comparing the exposure risk groups. Fisher’s exact test was performed to generate p values.
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FIGURE LEGENDS:
Figure 1. Airborne TDI levels for representative 6-week period. Y-axis depicts TDI
concentration in parts per billion, over time (X-axis). Each spike represents one 18
minute long period of measurement. Representative data from the cutting room are
shown for a 6-week period (Nov-Dec 2010). Long dashes are weekdays and stars
represent weekends. Boxed area is enlarged in Figure 2.
Figure 2. Airborne TDI levels for representative 6-day period. Y-axis depicts TDI
concentration in parts per billion, over time (X-axis). Area measurements for the 6-day
period (indicated in Fig. 1) highlight typical patterns of daily fluctuation.
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